Pioneering mRNA technology - Moderna
WEBmRNA medicine contains no animal products or preservatives, making medicine accessible for as many people as possible. Our platform enables rapid design, research and testing of multiple mRNAs, within days. Our novel production methods allow us to get medicines to more people, faster.
Moderna Achieves Positive Interim Results from Phase 3 Trial of …
WEBMar 26, 2024 · mRNA-1283 induced a more robust immune response compared to Spikevax® COVID-19 vaccine, mRNA-1273.222. Next-generation mRNA vaccine design offers the potential of longer shelf life and storage advantages, and paves the way for combination vaccine against influenza and COVID-19, mRNA-1083.
Moderna and OpenAI Collaborate To Advance mRNA Medicine
WEBApr 24, 2024 · Generative AI will help advance Moderna's broad and diverse portfolio to maximize the Company's impact on patients. Moderna embeds OpenAI's generative AI tools throughout its organization and sees early success with broad adoption of …
Moderna COVID-19 vaccine - Wikipedia
WEBThe Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA).
The Innovation System Behind Moderna’s Covid-19 Vaccine
WEBSeptember 23, 2021. Noubar Afeyan, cofounder and chair of Moderna Therapeutics and CEO of Flagship Pioneering, says that the breakthrough innovation behind the company’s Covid-19 vaccine came not...
Pioneering mRNA technology - Moderna
WEBTransforming medicine with mRNA. At Moderna, we believe the future of medicine is mRNA, the language of life inside every cell in our bodies. With our technology, we are researching and developing investigational mRNA vaccines and therapeutic approaches for infectious diseases, cancers, rare diseases, cardiovascular diseases, and autoimmune ...
Combined COVID–flu vaccines are coming: Moderna jab clears
WEBJun 28, 2024 · Pharmaceutical laboratories are researching new applications for mRNA vaccine technology — and Moderna is hoping to integrate COVID-19, influenza and respiratory syncytial virus immunization ...
How Moderna’s Covid-19 Vaccine Works - The New York Times
WEBModerna, a Massachusetts-based vaccine developer, partnered with the National Institutes of Health to develop and test a coronavirus vaccine known as mRNA-1273.
Moderna Announces Advancements in mRNA Platform Science …
WEBMay 17, 2022 · Moderna's mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and auto-immune diseases.
Moderna’s path to vaccine innovation: A talk with CEO …
WEBAug 27, 2021 · Moderna’s COVID-19 mRNA vaccine tells your cells to make a harmless viral protein called a spike. This stimulates your immune system to make antibodies and immune cells that counterattack the spike when they come across it.